{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:51:45Z","timestamp":1791161505961,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60308-0","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:57:21Z","timestamp":1783141041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fabrication of hybrid PCL-Chitosan\/PVA nanofibers by hybrid electrospinning for Local melanoma skin cancer therapy"],"prefix":"10.1038","volume":"16","author":[{"given":"Azam","family":"Jafari-Najaf-Abadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Pazoki-Toroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Mirjafary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hadjianfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"17","key":"60308_CR1","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.3390\/cancers17172920","volume":"17","author":"C Caraviello","year":"2025","unstructured":"Caraviello, C. et al. Melanoma skin cancer: A comprehensive review of current knowledge. Cancers 17 (17), 2920 (2025).","journal-title":"Cancers"},{"issue":"1","key":"60308_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","volume":"92","author":"Y Sun","year":"2025","unstructured":"Sun, Y. et al. Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990\u20132021. J. Am. Acad. Dermatol. 92 (1), 100\u2013107 (2025).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"60308_CR3","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s43018-024-00794-1","volume":"5","author":"BM Robertson","year":"2024","unstructured":"Robertson, B. M. et al. Determinants of resistance and response to melanoma therapy. Nat. Cancer. 5 (7), 964\u2013982 (2024).","journal-title":"Nat. Cancer"},{"issue":"8","key":"60308_CR4","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/cancers16081571","volume":"16","author":"A Fateeva","year":"2024","unstructured":"Fateeva, A. et al. Current state of melanoma therapy and next steps: battling therapeutic resistance. Cancers 16 (8), 1571 (2024).","journal-title":"Cancers"},{"key":"60308_CR5","doi-asserted-by":"publisher","first-page":"104724","DOI":"10.1016\/j.jddst.2023.104724","volume":"86","author":"L Fan","year":"2023","unstructured":"Fan, L. et al. Targeted nanoscale drug delivery systems for melanoma therapy. J. Drug Deliv. Sci. Technol. 86, 104724 (2023).","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"6","key":"60308_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s42452-025-06998-z","volume":"7","author":"M Fereidouni","year":"2025","unstructured":"Fereidouni, M. et al. Advances in the systemic administration of nanotechnology-mediated drug delivery systems in melanoma treatment: a systematic review. Discover Appl. Sci. 7 (6), 512 (2025).","journal-title":"Discover Appl. Sci."},{"key":"60308_CR7","doi-asserted-by":"publisher","first-page":"105342","DOI":"10.1016\/j.jddst.2024.105342","volume":"92","author":"S Muratoglu","year":"2024","unstructured":"Muratoglu, S. et al. Electrospun nanofiber drug delivery systems and recent applications: An overview. J. Drug Deliv. Sci. Technol. 92, 105342 (2024).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"60308_CR8","doi-asserted-by":"publisher","first-page":"151253","DOI":"10.1016\/j.cej.2024.151253","volume":"489","author":"G Kuang","year":"2024","unstructured":"Kuang, G. et al. Electrospun nanofibers-derived functional scaffolds for cancer therapy. Chem. Eng. J. 489, 151253 (2024).","journal-title":"Chem. Eng. J."},{"issue":"6","key":"60308_CR9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s42765-022-00198-9","volume":"4","author":"L Li","year":"2022","unstructured":"Li, L. et al. Electrospun fibers control drug delivery for tissue regeneration and cancer therapy. Adv. Fiber Mater. 4 (6), 1375\u20131413 (2022).","journal-title":"Adv. Fiber Mater."},{"issue":"11","key":"60308_CR10","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1039\/D2RA06023J","volume":"13","author":"MK Gaydhane","year":"2023","unstructured":"Gaydhane, M. K. et al. Electrospun nanofibers in drug delivery: advances in controlled release strategies. RSC Adv. 13 (11), 7312\u20137328 (2023).","journal-title":"RSC Adv."},{"issue":"1","key":"60308_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1039\/D2BM01513G","volume":"11","author":"S Tabakoglu","year":"2023","unstructured":"Tabakoglu, S. et al. Multifluid electrospinning for multi-drug delivery systems: Pros and cons, challenges, and future directions. Biomaterials Sci. 11 (1), 37\u201361 (2023).","journal-title":"Biomaterials Sci."},{"key":"60308_CR12","unstructured":"Concha, V. O. C. & et al. Harnessing electrospinning for improvement of polymeric drug delivery systems. Polymer Bulletin, 85, 1\u201335 (2025)."},{"key":"60308_CR13","doi-asserted-by":"publisher","first-page":"100710","DOI":"10.1016\/j.mtbio.2023.100710","volume":"21","author":"J Xing","year":"2023","unstructured":"Xing, J. et al. Multi-material electrospinning: from methods to biomedical applications. Mater. Today Bio. 21, 100710 (2023).","journal-title":"Mater. Today Bio"},{"key":"60308_CR14","doi-asserted-by":"publisher","first-page":"104909","DOI":"10.1016\/j.jddst.2023.104909","volume":"88","author":"R Yan","year":"2023","unstructured":"Yan, R. Dual drug-loaded core-shell nanofibers membranes via emulsion electrospinning and their controllable sustained release property. J. Drug Deliv. Sci. Technol. 88, 104909 (2023).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"60308_CR15","first-page":"66","volume":"35","author":"M Hezarkhani","year":"2022","unstructured":"Hezarkhani, M. et al. Fabrication methodologies of multi-layered and multi-functional electrospun structures by co-axial and multi-axial electrospinning techniques. Electrospun Nanofibers: Principles Technol. Novel Appl. 35, 66 (2022).","journal-title":"Electrospun Nanofibers: Principles Technol. Novel Appl."},{"issue":"1","key":"60308_CR16","first-page":"28401","volume":"15","author":"A Jafari-Najaf-Abadi","year":"2025","unstructured":"Jafari-Najaf-Abadi, A. et al. Core-shell nanofibers for localized melanoma therapy delivering pioglitazone nanoemulsions and gemcitabine dual loaded system. Sci. Reportes. 15 (1), 28401 (2025).","journal-title":"Sci. Reportes"},{"key":"60308_CR17","doi-asserted-by":"publisher","first-page":"141394","DOI":"10.1016\/j.ijbiomac.2025.141394","volume":"306","author":"MA Khorasani","year":"2025","unstructured":"Khorasani, M. A. et al. A review of chitosan-based multifunctional nanocomposites for drug\/gene\/protein delivery and gene therapy in cancer treatments: promises, challenges and outlooks. Int. J. Biol. Macromol. 306, 141394 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"60308_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ijbiomac.2022.12.056","volume":"226","author":"Z Chen","year":"2023","unstructured":"Chen, Z. Preparation and application of chitosan-based medical electrospun nanofibers. Int. J. Biol. Macromol. 226, 410\u2013422 (2023).","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"60308_CR19","first-page":"241","volume":"13","author":"M Yousefnezhad","year":"2023","unstructured":"Yousefnezhad, M. et al. PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy. Biolmpacts: Bl. 13 (3), 241 (2023).","journal-title":"Biolmpacts: Bl"},{"issue":"4","key":"60308_CR20","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3390\/app15041925","volume":"15","author":"M Vasileiou","year":"2025","unstructured":"Vasileiou, M. et al. Therapeutic potential and challenges of pioglitazone in cancer treatment. Appl. Sci. 15 (4), 1925 (2025).","journal-title":"Appl. Sci."},{"key":"60308_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.18433\/jpps30626","volume":"22","author":"N Dana","year":"2019","unstructured":"Dana, N. et al. PPAR\u03b3 agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling. J. Pharm. Pharm. Sci. 22, 418\u2013423 (2019).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"60308_CR22","doi-asserted-by":"publisher","first-page":"102039","DOI":"10.1016\/j.tranon.2024.102039","volume":"47","author":"F Asgharzadeh","year":"2024","unstructured":"Asgharzadeh, F. et al. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth. Translational Oncol. 47, 102039 (2024).","journal-title":"Translational Oncol."},{"issue":"2","key":"60308_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/molecules26020364","volume":"26","author":"A Hawrylkiewicz","year":"2021","unstructured":"Hawrylkiewicz, A. et al. Gemcitabine peptide-based conjugates and their application in targeted tumor therapy. Molecules 26 (2), 364 (2021).","journal-title":"Molecules"},{"issue":"3","key":"60308_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/nano11030597","volume":"11","author":"S Habib","year":"2021","unstructured":"Habib, S. et al. Recent advances in lipid-based nanosystems for gemcitabine and gemcitabine-combination therapy. Nanomaterials 11 (3), 597 (2021).","journal-title":"Nanomaterials"},{"key":"60308_CR25","doi-asserted-by":"publisher","first-page":"105156","DOI":"10.1016\/j.jddst.2023.105156","volume":"90","author":"R Abdulhussain","year":"2023","unstructured":"Abdulhussain, R. et al. Electrospun nanofibers: Exploring process parameters, polymer selection, and recent applications in pharmaceuticals and drug delivery. J. Drug Deliv. Sci. Technol. 90, 105156 (2023).","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"11","key":"60308_CR26","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/nano14110949","volume":"14","author":"C Dragar","year":"2024","unstructured":"Dragar, C. et al. The incorporated drug affects the properties of hydrophilic nanofibers. Nanomaterials 14 (11), 949 (2024).","journal-title":"Nanomaterials"},{"key":"60308_CR27","doi-asserted-by":"publisher","unstructured":"Kalluri, L. et al. Effect of electrospinning parameters on the fiber diameter and morphology of PLGA nanofibers. Dent. Oral Biology Craniofac. Res. 4 (2). https:\/\/doi.org\/10.31487\/j.dobcr (2021). 2021.02.04.","DOI":"10.31487\/j.dobcr"},{"issue":"1","key":"60308_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3762\/bjnano.13.19","volume":"13","author":"TE Boncu","year":"2022","unstructured":"Boncu, T. E. et al. Effects of drug concentration and PLGA addition on the properties of electrospun ampicillin trihydrate-loaded PLA nanofibers. Beilstein J. Nanotechnol. 13 (1), 245\u2013254 (2022).","journal-title":"Beilstein J. Nanotechnol."},{"key":"60308_CR29","doi-asserted-by":"crossref","unstructured":"Tomar, S. et al. Current approaches in nanofiber-based drug delivery systems: methods and applications. Fiber Text. Eng. drug delivery systems, 39\u201371 (2023).","DOI":"10.1016\/B978-0-323-96117-2.00014-5"},{"key":"60308_CR30","doi-asserted-by":"publisher","first-page":"120168","DOI":"10.1016\/j.ces.2024.120168","volume":"295","author":"N Joy","year":"2024","unstructured":"Joy, N. et al. Connecting in situ cone\/jet length in electrospinning to fiber diameter and drug release for the rational design of electrospun drug carriers. Chem. Eng. Sci. 295, 120168 (2024).","journal-title":"Chem. Eng. Sci."},{"key":"60308_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.eng.2021.02.025","volume":"13","author":"D Li","year":"2022","unstructured":"Li, D. et al. Fabrication and applications of multi-fluidic electrospinning multi-structure hollow and core-shell nanofibers. Engineering 13, 116\u2013127 (2022).","journal-title":"Engineering"},{"issue":"11","key":"60308_CR32","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3390\/nano12111829","volume":"12","author":"S Nirwan","year":"2022","unstructured":"Nirwan, S. Advances in electrospun hybrid nanofibers for biomedical applications. Nanomaterials 12 (11), 1829 (2022).","journal-title":"Nanomaterials"},{"issue":"2","key":"60308_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/fib11020021","volume":"11","author":"S Farhaj","year":"2023","unstructured":"Farhaj, S. et al. Nanofibers in drug delivery applications. Fibers 11 (2), 21 (2023).","journal-title":"Fibers"},{"issue":"12","key":"60308_CR34","first-page":"78","volume":"33","author":"X Duan","year":"2022","unstructured":"Duan, X. et al. Polymeric nanofibers for drug delivery applications: a recent review. J. Mater. Science: Mater. Med. 33 (12), 78 (2022).","journal-title":"J. Mater. Science: Mater. Med."},{"issue":"13","key":"60308_CR35","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.biomaterials.2008.01.011","volume":"29","author":"TJ Sill","year":"2008","unstructured":"Sill, T. J. et al. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 29 (13), 1989\u20132006 (2008).","journal-title":"Biomaterials"},{"key":"60308_CR36","doi-asserted-by":"crossref","unstructured":"Ravi Kumar, M. N. V. A review of chitin and chitosan applications. Reactive Funct. Polymers 46(1), 1\u201327 (2001).","DOI":"10.1016\/S1381-5148(00)00038-9"},{"issue":"2","key":"60308_CR37","first-page":"441","volume":"14","author":"NA Peppas","year":"1976","unstructured":"Peppas, N. A. et al. Poly (vinyl alcohol) hydrogels: reinforcement of radiation-crosslinked networks by crystallization. J. Polym. science: Polym. Chem. Ed. 14 (2), 441\u2013457 (1976).","journal-title":"J. Polym. science: Polym. Chem. Ed."},{"issue":"1\u20132","key":"60308_CR38","first-page":"241","volume":"518","author":"X Zhao","year":"2017","unstructured":"Zhao, X. et al. Design of pioglitazone-loaded electrospun nanofibers for sustained drug release and enhanced antitumor efficacy. Int. J. Pharm. 518 (1\u20132), 241\u2013251 (2017).","journal-title":"Int. J. Pharm."},{"key":"60308_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejphar.2016.05.016","volume":"784","author":"M Parsian","year":"2016","unstructured":"Parsian, M. et al. Loading of Gemcitabine on chitosan magnetic nanoparticles increase the anti-cancer efficacy of the drug. Eur. J. Pharmacol. 784, 121\u2013128 (2016).","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"60308_CR40","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1021\/acs.chemrev.8b00593","volume":"119","author":"J Xue","year":"2019","unstructured":"Xue, J. et al. Electrospinning and electrospun nanofibers: methods, materials, and applications. Chem. Rev. 119 (8), 5298\u20135415 (2019).","journal-title":"Chem. Rev."},{"issue":"1\u20132","key":"60308_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0168-3659(02)00041-X","volume":"81","author":"E-R Kenawy","year":"2002","unstructured":"Kenawy, E-R. et al. Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), and a blend. J. Controlled Release. 81 (1\u20132), 57\u201364 (2002).","journal-title":"J. Controlled Release"},{"issue":"5","key":"60308_CR42","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s12221-024-00548-x","volume":"25","author":"C Bulbul","year":"2024","unstructured":"Bulbul, C. Polycaprolactone-based composite electrospun nanofibers as hybrid biomaterial systems containing hydroxyl-or carboxylic acid-functionalized multiwall carbon nanotubes. Fibers ad Polym. 25 (5), 1701\u20131712 (2024).","journal-title":"Fibers ad Polym."},{"key":"60308_CR43","doi-asserted-by":"publisher","unstructured":"Sayed, M. M. et al. Environmentally fiiendly electrospun polycaprolactone bio-membrane fabrication for water distillation. Materials Today: preceedings https:\/\/doi.org\/10.1016\/j.matpr.2023.09.017 (2023).","DOI":"10.1016\/j.matpr.2023.09.017"},{"key":"60308_CR44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.polymer.2019.02.023","volume":"168","author":"MA Nazeer","year":"2019","unstructured":"Nazeer, M. A. et al. Electrospun polycaprolactone\/silk fibroin nanofibrous bioactive scaffolds for tissue engineering applications. Polymer 168, 86\u201394 (2019).","journal-title":"Polymer"},{"key":"60308_CR45","doi-asserted-by":"publisher","first-page":"110580","DOI":"10.1016\/j.matdes.2022.110580","volume":"216","author":"IS Raja","year":"2022","unstructured":"Raja, I. S. et al. The predominant factor influencing cellular behaviour on electrospun nanofibrous scaffolds: Wettability or surface morphology? Mater. Design. 216, 110580 (2022).","journal-title":"Mater. Design"},{"issue":"1","key":"60308_CR46","first-page":"71","volume":"15","author":"HT Nguyen","year":"2024","unstructured":"Nguyen, H. T. et al. Berberine-loaded polylactic acid nanofiber scaffold as a drug delivery system: The relationship between chemical characteristics, drug-release behaviour, and antibacterial efficiency. Beilstein J. Nanotechnol. 15 (1), 71\u201382 (2024).","journal-title":"Beilstein J. Nanotechnol."},{"issue":"17","key":"60308_CR47","doi-asserted-by":"publisher","first-page":"9517","DOI":"10.3390\/ijms23179517","volume":"23","author":"HH Kao","year":"2022","unstructured":"Kao, H. H. et al. Polycaprolactone\/chitosan composite nanofiber membrane as a preferred scaffold for the culture of mesothelial cells and the repair of damaged mesothelium. Int. J. Mol. Sci. 23 (17), 9517 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"60308_CR48","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ijbiomac.2018.10.022","volume":"121","author":"A Sadeghi","year":"2019","unstructured":"Sadeghi, A. et al. Investigating the effect of chitosan on hydrophilicity and bioactivity of conductive electrospun composite scaffold for neural tissue engineering. Int. J. Biol. Macromol. 121, 625\u2013632 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"60308_CR49","doi-asserted-by":"crossref","unstructured":"Noori, F. et al. Fabrication and in vivo evaluation of hybrid squalene-loaded nanofiber scaffolds based on poly(\u025b-caprolactone)\/polyvinyl alcohol\/chitosan for wound healing applications. Journal Polym. Environment 33, 2515-2536 (2025).","DOI":"10.1007\/s10924-025-03543-2"},{"issue":"9","key":"60308_CR50","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/foods13091385","volume":"13","author":"K Ahn","year":"2024","unstructured":"Ahn, K. et al. New surface modification of hydrophilic polyvinyl alcohol via predrying and electrospinning of Hydrophobic polycaprolactone nanofibers. Foods 13 (9), 1385 (2024).","journal-title":"Foods"},{"key":"60308_CR51","doi-asserted-by":"crossref","unstructured":"Sumathi, S. A review of electrospun polymeric fibers as potential drug delivery systems for tunable release kinetics. Journal Science: Adv. Mater. Devices 10, 100933 (2025).","DOI":"10.1016\/j.jsamd.2025.100933"},{"issue":"11","key":"60308_CR52","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3390\/polym12112636","volume":"12","author":"B Niemczyk-Soczynska","year":"2020","unstructured":"Niemczyk-Soczynska, B. et al. Hydrophilic surface functionalization of electrospun nanofibrous scaffolds in tissue engineering. Polymers 12 (11), 2636 (2020).","journal-title":"Polymers"},{"issue":"5","key":"60308_CR53","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/17425247.2023.2210834","volume":"20","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. Biphasic drug release from electrospun structures. Expert Opin. Drug Deliv. 20 (5), 621\u2013640 (2023).","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"60308_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/jfb13040289","volume":"13","author":"P Wang","year":"2022","unstructured":"Wang, P. Progress of electrospun nanofibrous carriers for modifucations to drug release profiles. J. Funct. Biomaterials. 13 (4), 289 (2022).","journal-title":"J. Funct. Biomaterials"},{"issue":"2","key":"60308_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s42765-021-00112-9","volume":"4","author":"H He","year":"2022","unstructured":"He, H. et al. Engineered spindles of little molecules around electrospun nanofibers for biphasic drug release. Adv. Fiber Mater. 4 (2), 305\u2013317 (2022).","journal-title":"Adv. Fiber Mater."},{"key":"60308_CR56","doi-asserted-by":"publisher","first-page":"107255","DOI":"10.1016\/j.jddst.2025.107255","volume":"112","author":"Y Wondwosen Ahmed","year":"2025","unstructured":"Wondwosen Ahmed, Y. et al. Synergistic local delivery of gemcitabine and resiquimod (R848) via janus micelles encapsulated in a dual-responsive hydrogel for subcutaneous glioblastoma treatment models. J. Drug Deliv. Sci. Technol. 112, 107255 (2025).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"60308_CR57","doi-asserted-by":"publisher","first-page":"125320","DOI":"10.1016\/j.cej.2020.125320","volume":"396","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Sustained release of lipophilic gemcitabine from an injectable polymeric hydrogel for synergistically enhancing tumor chemoradiotherapy. Chem. Eng. J. 396, 125320 (2020).","journal-title":"Chem. Eng. J."},{"key":"60308_CR58","doi-asserted-by":"publisher","first-page":"106520","DOI":"10.1016\/j.jddst.2024.106520","volume":"104","author":"AJ Kyser","year":"2025","unstructured":"Kyser, A. J. et al. Electrospun nanofibers: Focus on local therapeutic delivery targeting infectious disease. J. Drug Deliv. Sci. Technol. 104, 106520 (2025).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"60308_CR59","doi-asserted-by":"publisher","first-page":"103246","DOI":"10.1016\/j.jddst.2022.103246","volume":"71","author":"M Alimohammadi","year":"2022","unstructured":"Alimohammadi, M. et al. Controlled release of azithromycin from polycaprolactone\/chitosan nanofibrous membranes. J. Drug Deliv. Sci. Technol. 71, 103246 (2022).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"60308_CR60","doi-asserted-by":"publisher","first-page":"136894","DOI":"10.1016\/j.matlet.2024.136894","volume":"371","author":"I Corvaglia","year":"2024","unstructured":"Corvaglia, I. et al. Electrospun marices for sustained drug release made by a PCL-chitosan blend shell and a PVA core. Mater. Lett. 371, 136894 (2024).","journal-title":"Mater. Lett."},{"key":"60308_CR61","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jconrel.2020.11.036","volume":"330","author":"X Lan","year":"2021","unstructured":"Lan, X. et al. Multidrug-loaded electrospun micro\/nanofibrous membranes: Fabrication strategies, release behaviors and applications in regenerative medicine. J. Controlled Release. 330, 1264\u20131287 (2021).","journal-title":"J. Controlled Release"},{"issue":"22","key":"60308_CR62","doi-asserted-by":"publisher","first-page":"7062","DOI":"10.3390\/ma16227062","volume":"16","author":"M Wildy","year":"2023","unstructured":"Wildy, M. et al. Electrospun nanofibers: shaping the future of controlled and responsive drug delivery. Materials 16 (22), 7062 (2023).","journal-title":"Materials"},{"issue":"3","key":"60308_CR63","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.biotechadv.2010.01.004","volume":"28","author":"N Bhardwaj","year":"2010","unstructured":"Bhardwaj, N. et al. Electrospinning: A fascinating fiber fabrication technique. Biotechnol. Adv. 28 (3), 325\u2013347 (2010).","journal-title":"Biotechnol. Adv."},{"issue":"9","key":"60308_CR64","first-page":"434","volume":"26","author":"JR Colca","year":"2015","unstructured":"Colca, J. R. The TZD insulin sensitizers: The emerging role of PPAR\u03b3-independent mechanisms. Trends Endocrinol. Metab. 26 (9), 434\u2013444 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"60308_CR65","doi-asserted-by":"publisher","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","volume":"17","author":"E Mini","year":"2006","unstructured":"Mini, E. et al. Cellular pharmacology of gemcitabine. Ann. Oncol. 17, v7\u2013v12 (2006).","journal-title":"Ann. Oncol."},{"issue":"2","key":"60308_CR66","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.canlet.2013.02.055","volume":"335","author":"SH Yang","year":"2013","unstructured":"Yang, S. H. & Et Combination of gemcitabine and pioglitazone enhances antitumor effect in human colon cancer cells. Cancer Lett. 335 (2), 421\u2013429 (2013).","journal-title":"Cancer Lett."},{"key":"60308_CR67","unstructured":"Huang, P. et al. Induction of apoptosis by gemcitabine. Seminars in oncology. 22(4 suppl 11), 19\u201325 (1995)."},{"issue":"4","key":"60308_CR68","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/polym16040504","volume":"16","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Application of electrospun drug-loaded nanofibers in cancer therapy. Polymers 16 (4), 504 (2024).","journal-title":"Polymers"},{"key":"60308_CR69","doi-asserted-by":"publisher","first-page":"928797","DOI":"10.3389\/fonc.2022.928797","volume":"12","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Nanoparticle-based combination therapy for melanoma. Front. Oncol. 12, 928797 (2022).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60308-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60308-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60308-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:02:50Z","timestamp":1791158570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60308-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60308"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60308-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human participants or animals. All experiments were performed using the A375 human melanoma cell line, and no informed consent was required. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30724"}}